BioLineRx Ltd.

Tel Aviv Stock Exchange:BLRX.TA

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

Israel

Market Cap

USD 14.92 M

Share Price

USD 0.01

Avg Daily Volume

9,388,393

Change (1 day)

0.30%

Change (1 year)

-83.97%

Change (YTD)

-62.56%

BioLineRx Ltd. Accounts Payable for the year ending December 31, 2023: USD 10.87 M

BioLineRx Ltd. Accounts Payable is USD 10.87 M for the year ending December 31, 2023. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Competitors

Eli Lilly and Company

USD 746.37

LLY

-19.58 -2.56%

AbbVie Inc.

USD 196.30

ABBV

-2.25 -1.13%

Roche Holding AG

USD 322.52

RO.SW

-10.06 -3.03%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Novartis AG

USD 114.49

NOVN.SW

-3.72 -3.15%

Novo Nordisk A/S

USD 45.10

NOVO-B.CO

-2.22 -4.69%

Merck & Co., Inc.

USD 79.44

MRK

-1.35 -1.67%

Thermo Fisher Scientific Inc.

USD 448.94

TMO

-17.48 -3.75%

Amgen Inc.

USD 284.67

AMGN

-15.41 -5.13%

Pfizer Inc.

USD 23.93

PFE

-0.82 -3.31%

Gilead Sciences, Inc.

USD 110.28

GILD

-2.18 -1.94%

Sanofi

USD 92.89

SAN.PA

-2.06 -2.17%

Vertex Pharmaceuticals Incorporated

USD 385.65

VRTX

+10.67 2.84%

Bristol-Myers Squibb Company

USD 44.82

BMY

-1.03 -2.25%

Chugai Pharmaceutical Co., Ltd.

USD 49.92

4519.T

-0.37 -0.73%

View all

Key Data

Date	Accounts Payable	Short-Term Debt	Long-Term Debt	Total Liabilities